Lasa Supergenerics Limited

NSE LASA.NS

Lasa Supergenerics Limited Shares (Diluted, Weighted) for the year ending March 31, 2024: 50,101,239

Lasa Supergenerics Limited Shares (Diluted, Weighted) is 50,101,239 for the year ending March 31, 2024, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Lasa Supergenerics Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 50,101,239, a 0.00% change year over year.
Lasa Supergenerics Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 50,101,239, a 23.18% change year over year.
Lasa Supergenerics Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 40,672,668, a 0.00% change year over year.
Lasa Supergenerics Limited Shares (Diluted, Weighted) for the year ending March 31, 2020 was 40,672,668, a 77.89% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NSE: LASA.NS

Lasa Supergenerics Limited

CEO	Dr. Omkar Pravin Herlekar
IPO Date	Sept. 21, 2017
Location	India
Headquarters	No. 506 & 507, Midas Sahar Plaza
Employees	77
Sector	Consumers Staples
Industries Pet Food Agriculture Biotechnology Cleaning Supplies Cosmetics Dairy & Milk Personal Care Pharmaceuticals

Description

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.

Key trends

Past 5 years